Ataxia Gene Panel in UAE | 4800 AED | DHA-Accredited Molecular Diagnostics

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS processing.

Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.

Clinical Guidance: Complimentary telephonic post‑test clinical guidance with a DHA‑licensed genetic counsellor.

Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731. Pre‑approval handled for all major UAE networks.

Test Overview & Methodology

The Ataxia Gene Panel utilises Next‑Generation Sequencing (NGS) to simultaneously analyse over 200 genes associated with hereditary ataxias, enabling precise diagnosis, family screening, and personalised management plans. Our Dubai‑based DHA‑accredited laboratory delivers definitive molecular results within 4–6 weeks, strictly following international ACMG guidelines.

Feature	Our Ataxia Gene Panel	Closest Alternative (WES)
Methodology	Targeted NGS (200+ genes)	Whole Exome Sequencing
Diagnostic Precision	High depth, low VUS rate	Many variants of uncertain significance
Turnaround Time	4–6 weeks	8–12 weeks typical
Cost–Effectiveness	4800 AED, insurance direct‑bill	Often >7000 AED, may not be fully covered

Physician Insight & Safety Protocols

“The Ataxia Gene Panel provides a molecular roadmap for families navigating hereditary ataxia. However, results must be interpreted within the full clinical context — including neurological examination and family history. Do not alter any treatment plan without discussing the findings with your specialist.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Important Advisory: Pre-Test Requirements & Medication Safety

A valid prescription from a DHA‑licensed physician is required. In cases of pregnancy, planned surgery, or travel abroad, the test may be performed without a prescription, but a mandatory clinical consultation is required before sample collection.
No drug or dietary supplement avoidance is needed prior to specimen collection.
For amniotic fluid or chorionic villus sampling, an obstetrical referral and ultrasound guidance are essential.
Medication Warning: Do not discontinue or adjust any prescribed medication without consulting your treating physician. Genetic results are only one piece of your overall health picture.

Exclusion Criteria & Emergency Red Flags

Exclusion: Acute febrile illness, active infection, or inability to provide informed consent. Phlebotomy contraindicated in severe coagulopathy (assess before blood draw).
Emergency Signs: If you experience sudden loss of balance with slurred speech, severe headache, vision changes, or altered consciousness, seek emergency care immediately — do not wait for panel results.

Patient FAQ & Clinical Guidance

1. What is the Ataxia Gene Panel?

The Ataxia Gene Panel uses next-generation sequencing to analyse over 200 genes linked to hereditary ataxias, guiding accurate diagnosis and family risk assessment. It is the most cost‑effective molecular test for patients with progressive imbalance, dysarthria, or abnormal eye movements, and can detect both dominant and recessive forms.

2. How is the sample collected and how long until I get results?

Sample collection is performed exclusively at a DHA‑accredited hospital facility. A blood draw or, when clinically indicated, an amniotic fluid sample is obtained under medical supervision. Results are available within 4–6 weeks, with a detailed molecular report and bilingual clinical summary.

3. Does UAE insurance cover the Ataxia Gene Panel?

Most major UAE insurers cover the Ataxia Gene Panel when it is medically necessary; we provide direct billing and verification via WhatsApp at +971 54 548 8731. Our team obtains pre‑approval on your behalf, ensuring compliance with your policy’s genetic testing clauses.

UAE Regulatory & Data Privacy Adherence

Our laboratory operations strictly comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑controlled, and used solely for diagnostic purposes with explicit patient consent. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name	Ataxia Gene Panel
Price (AED)	4,800 AED
Turnaround Time	4–6 weeks
Sample Type / Matrix	Peripheral whole blood or amniotic fluid (hospital extraction only)
Methodology Used	Next-Generation Sequencing (NGS), targeted panel
ICD-10-CM Code	G11.9
LOINC Code	96534-4
DHA Facility License & Laboratory Address	DHA License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE